Holen Sie sich die Stockscreener-App
27.03
3.25%
0.8173
Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten
AnaptysBio Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockHigh-yield portfolio picks - jammulinksnews.com
How AnaptysBio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
Is AnaptysBio Inc. a good long term investmentConsistent high-yield stocks - jammulinksnews.com
What drives AnaptysBio Inc. stock priceFree Stock Market Knowledge Sharing - jammulinksnews.com
AnaptysBio, Inc.'s (NASDAQ:ANAB) Share Price Not Quite Adding Up - simplywall.st
What makes AnaptysBio Inc. stock price move sharplyShort Squeeze Radar - Newser
Why AnaptysBio Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
AnaptysBio (ANAB) Soars 2.86% on Two Sigma Stake Increase - AInvest
AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB) - Seeking Alpha
(ANAB) Trading Report - news.stocktradersdaily.com
AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.6%What's Next? - MarketBeat
Moody Aldrich Partners LLC Acquires New Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Director Sells $493,202.25 in Stock - MarketBeat
AnaptysBio, Inc. (ANAB) Stock Analysis: A High-Risk, High-Reward Bet with a 79% Potential Upside - DirectorsTalk Interviews
(ANAB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Farther Finance Advisors LLC Increases Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
GAMMA Investing LLC Acquires New Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
When the Price of (ANAB) Talks, People Listen - news.stocktradersdaily.com
Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
Assenagon Asset Management S.A. Has $4.51 Million Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Holdings Trimmed by Bank of America Corp DE - MarketBeat
AnaptysBio Holds 2025 Annual Stockholders Meeting - TipRanks
Bank of America Corp DE Lowers Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by California State Teachers Retirement System - Defense World
FMR LLC Significantly Reduces Stake in AnaptysBio Inc - GuruFocus
Stocks With Rising Relative Price Strength: AnaptysBio - Investor's Business Daily
JPMorgan Sees AnaptysBio (ANAB) as Undervalued Due to Rosnilimab - GuruFocus
Shareholders May Be More Conservative With AnaptysBio, Inc.'s (NASDAQ:ANAB) CEO Compensation For Now - simplywall.st
New RA Drug Shown to Work, Be Safe - streetwisereports.com
AnaptysBio: Rosnilimab's RA Data Sets The Stage For Blockbuster Potential (NASDAQ:ANAB) - Seeking Alpha
ANAB Schedules June 9 Conference Call with JPMorgan | ANAB Stock News - GuruFocus
Brokerages Set AnaptysBio, Inc. (NASDAQ:ANAB) Price Target at $42.38 - MarketBeat
AnaptysBio (NASDAQ:ANAB) Trading Down 4.5%Time to Sell? - MarketBeat
AnaptysBio (NASDAQ:ANAB) Upgraded by HC Wainwright to "Buy" Rating - MarketBeat
AnaptysBio (NASDAQ:ANAB) Shares Gap UpHere's What Happened - MarketBeat
4.79%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):